The impact of tezepelumab therapy on perceived asthma triggers: a multicenter real-life study
Tezepelumab positively impacts patients' perception of asthma triggers and their HRQoL, supporting its role in managing triggers hypersensitivity as a treatable trait in severe asthma. Further research is warranted to investigate underlying mechanisms and long-term effects.
Authors
- Andrea Portacci (ORCID: https://orcid.org/0000-0002-6127-2486)
- Francesca Montagnolo
- Donato Lacedonia (ORCID: https://orcid.org/0000-0003-0429-7967)
- Giulia Scioscia (ORCID: https://orcid.org/0000-0002-2667-077X)
- Maria Aliani (ORCID: https://orcid.org/0000-0001-8753-1303)
- Ernesto Lulaj
- Giovanna Elisiana Carpagnano (ORCID: https://orcid.org/0000-0001-7931-4704)
- Silvano Dragonieri (ORCID: https://orcid.org/0000-0003-1563-6864)
- Luciana Salerno
- Piera Soccio (ORCID: https://orcid.org/0000-0003-0151-9093)
- Pietro Magaletti
Institutions
- University of Foggia (IT)
- Istituti Clinici Scientifici Maugeri (IT)
Publication Details
- Journal
- Journal of Asthma
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1080/02770903.2025.2495725
- Citations
- 2
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.33